Evaluating the need for late angiography for complete obliteration of AVMs after endovascular treatment: collaborative AVM center experience and a systematic review.

J Neurointerv SurgSep 14, 2026 (epub)

Elle Vermeulen, Michael Bruneau, Fons Potters et al.

✦ AI-curated · Sources linked

In 30 seconds

This study evaluated late recanalization rates of brain arteriovenous malformations (bAVMs) after complete endovascular treatment in a cohort of 42 adult patients. The retrospective cohort study found that 90.5% achieved complete obliteration, with a late recurrence rate of 9.5% detected at 5- and 6-year follow-ups. A systematic review of 19 patients showed no late recurrences.

Key findings

  • 90.5% of patients achieved confirmed complete obliteration after endovascular treatment.
  • Two late recurrences (9.5%) were detected at 5- and 6-year follow-ups.
  • The systematic review found no late recurrences in 19 patients with a mean follow-up of 20.8 months.

Why it matters

Understanding late recanalization rates is crucial for managing bAVMs post-treatment. This study highlights the importance of long-term follow-up to ensure complete obliteration and to identify potential recurrences.

Source

Published in J Neurointerv Surg. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurosurgery

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.